Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Overall, many patients in both groups explored other weight-management treatment options within 12 months of stopping their initial GLP-1 injectable: Researchers say the findings underscore the importance of personalized, ongoing support for patients seeking obesity treatment even when they stop medication
doi: 10.1038/s41586-022-04559-7 96 ZhaoBDuFXuPShuCSankaranBBellSLet al
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1 Trial)
Mild, occasional vomiting does not necessarily require stopping treatment, as symptoms often improve with dietary modifications and time
10.1057/jfns000028 215
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
